Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.40 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.40 |
| ▸ | NR3C1 | P04150 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.37 |
| ▸ | CTBP2 | P56545 | 1/20 | 0.37 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.37 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.37 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.36 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15976426 | 0.83 | TAAR1 (0.45) | TAAR1SSTR4NR3C2NR3C1HPGD | |
| SCHEMBL13722854 | 0.83 | TAAR1 (0.45) | TAAR1SSTR4NR3C2NR3C1HPGD | |
| SCHEMBL808983 | 0.83 | TAAR1 (0.45) | TAAR1SSTR4NR3C2NR3C1HPGD | |
| SCHEMBL19085950 | 0.83 | TAAR1 (0.45) | TAAR1SSTR4NR3C2NR3C1HPGD | |
| SCHEMBL24848861 | 0.79 | TAAR1 (0.42) | TAAR1SSTR4NR3C2NR3C1HPGD | |
| SCHEMBL3167835 | 0.78 | RIPK1 (0.48) | TAAR1SSTR4NR3C2NR3C1HPGD | |
| SCHEMBL14142999 | 0.76 | TAAR1 (0.39) | TAAR1SSTR4NR3C2NR3C1HPGD | |
| SCHEMBL2958719 | 0.75 | TAAR1 (0.42) | TAAR1SSTR4NR3C2NR3C1HPGD | |
| SCHEMBL3638610 | 0.74 | TAAR1 (0.52) | TAAR1SSTR4NR3C2ALDH1A1ADRB2 | |
| SCHEMBL29987056 | 0.74 | TAAR1 (0.52) | TAAR1SSTR4NR3C2ALDH1A1ADRB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2585569-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2013-05-01 | — | — | EP | claimed |
| WO-2011163337-A1 | PERFUME SYSTEMS | THE PROCTER & GAMBLE COMPANY (US) | 2011-12-29 | — | — | WO | claimed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | claimed |
| EP-3085759-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-07 | — | — | EP | disclosed |
| EP-3085759-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2018-02-07 | — | — | EP | disclosed |
| EP-3085759-A2 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2016-10-26 | — | — | EP | disclosed |
| EP-3085759-A2 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2016-10-26 | — | — | EP | disclosed |
| EP-2585569-B1 | PERFUME SYSTEMS | PROCTER & GAMBLE (US) | 2016-08-24 | — | — | EP | disclosed |
| US-8609603-B2 | Perfume systems | THE PROCTER & GAMBLE COMPANY (US) | 2013-12-17 | — | — | US | disclosed |
| EP-2585569-A1 | PERFUME SYSTEMS | The Procter and Gamble Company (US) | 2013-05-01 | — | — | EP | disclosed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
| US-20110308555-A1 | PERFUME SYSTEMS | PROCTER & GAMBLE COMPANY, THE | 2011-12-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110308555-A1 | PERFUME SYSTEMS | TRPA1, PORCN, PLIN5 | TAAR1 615/4885SSTR4 2383/4885NR3C2 4575/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.